Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HGZ5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 110 | 114 | PF00656 | 0.407 |
CLV_C14_Caspase3-7 | 156 | 160 | PF00656 | 0.475 |
CLV_PCSK_SKI1_1 | 43 | 47 | PF00082 | 0.414 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.545 |
DEG_SPOP_SBC_1 | 123 | 127 | PF00917 | 0.309 |
DOC_CKS1_1 | 53 | 58 | PF01111 | 0.532 |
DOC_MAPK_gen_1 | 133 | 142 | PF00069 | 0.515 |
DOC_MAPK_gen_1 | 64 | 71 | PF00069 | 0.475 |
DOC_MAPK_MEF2A_6 | 136 | 144 | PF00069 | 0.436 |
DOC_MAPK_MEF2A_6 | 15 | 24 | PF00069 | 0.426 |
DOC_MAPK_MEF2A_6 | 64 | 71 | PF00069 | 0.475 |
DOC_PP1_RVXF_1 | 13 | 20 | PF00149 | 0.550 |
DOC_PP1_RVXF_1 | 66 | 72 | PF00149 | 0.468 |
DOC_PP2B_LxvP_1 | 96 | 99 | PF13499 | 0.509 |
DOC_PP4_FxxP_1 | 118 | 121 | PF00568 | 0.343 |
DOC_PP4_FxxP_1 | 81 | 84 | PF00568 | 0.481 |
DOC_USP7_MATH_1 | 121 | 125 | PF00917 | 0.522 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.398 |
DOC_WW_Pin1_4 | 142 | 147 | PF00397 | 0.467 |
DOC_WW_Pin1_4 | 52 | 57 | PF00397 | 0.629 |
LIG_14-3-3_CanoR_1 | 25 | 29 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 91 | 96 | PF00244 | 0.302 |
LIG_Actin_WH2_2 | 10 | 27 | PF00022 | 0.523 |
LIG_BIR_III_4 | 150 | 154 | PF00653 | 0.452 |
LIG_FHA_1 | 123 | 129 | PF00498 | 0.436 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.638 |
LIG_LIR_Gen_1 | 147 | 157 | PF02991 | 0.511 |
LIG_LIR_Gen_1 | 42 | 53 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 147 | 152 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 16 | 22 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 42 | 48 | PF02991 | 0.439 |
LIG_PDZ_Class_2 | 174 | 179 | PF00595 | 0.539 |
LIG_Pex14_2 | 71 | 75 | PF04695 | 0.344 |
LIG_SH2_STAP1 | 4 | 8 | PF00017 | 0.464 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.521 |
LIG_SH3_3 | 14 | 20 | PF00018 | 0.529 |
LIG_SH3_3 | 50 | 56 | PF00018 | 0.558 |
LIG_SUMO_SIM_anti_2 | 86 | 91 | PF11976 | 0.329 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.437 |
MOD_CK1_1 | 3 | 9 | PF00069 | 0.611 |
MOD_CK1_1 | 57 | 63 | PF00069 | 0.522 |
MOD_CK2_1 | 157 | 163 | PF00069 | 0.593 |
MOD_GlcNHglycan | 56 | 59 | PF01048 | 0.435 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.576 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.622 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.416 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.430 |
MOD_NEK2_1 | 140 | 145 | PF00069 | 0.364 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.509 |
MOD_NEK2_1 | 71 | 76 | PF00069 | 0.491 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.393 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.315 |
MOD_Plk_1 | 6 | 12 | PF00069 | 0.500 |
MOD_Plk_4 | 24 | 30 | PF00069 | 0.421 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.382 |
MOD_ProDKin_1 | 142 | 148 | PF00069 | 0.472 |
MOD_ProDKin_1 | 52 | 58 | PF00069 | 0.634 |
MOD_SUMO_rev_2 | 38 | 45 | PF00179 | 0.432 |
TRG_DiLeu_BaEn_1 | 18 | 23 | PF01217 | 0.486 |
TRG_DiLeu_BaLyEn_6 | 112 | 117 | PF01217 | 0.404 |
TRG_ER_diArg_1 | 66 | 69 | PF00400 | 0.263 |
TRG_Pf-PMV_PEXEL_1 | 155 | 159 | PF00026 | 0.327 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKA8 | Leptomonas seymouri | 46% | 99% |
A0A0S4J055 | Bodo saltans | 34% | 95% |
A0A1X0NR08 | Trypanosomatidae | 30% | 87% |
A0A3R7KM85 | Trypanosoma rangeli | 31% | 100% |
A0A3S7X216 | Leishmania donovani | 79% | 100% |
A4I427 | Leishmania infantum | 79% | 100% |
D0A8Y0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 100% |
E9B0B4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4Q7X0 | Leishmania major | 81% | 99% |